Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $57.7 million.

  • Orthopediatrics' Cash & Current Investments fell 2410.6% to $57.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.7 million, marking a year-over-year decrease of 2410.6%. This contributed to the annual value of $68.8 million for FY2024, which is 1428.66% down from last year.
  • According to the latest figures from Q3 2025, Orthopediatrics' Cash & Current Investments is $57.7 million, which was down 2410.6% from $70.1 million recorded in Q2 2025.
  • Orthopediatrics' 5-year Cash & Current Investments high stood at $118.3 million for Q4 2022, and its period low was $30.9 million during Q2 2024.
  • For the 5-year period, Orthopediatrics' Cash & Current Investments averaged around $69.8 million, with its median value being $68.8 million (2024).
  • Its Cash & Current Investments has fluctuated over the past 5 years, first surged by 13926.71% in 2023, then plummeted by 6685.09% in 2024.
  • Quarter analysis of 5 years shows Orthopediatrics' Cash & Current Investments stood at $53.5 million in 2021, then skyrocketed by 120.93% to $118.3 million in 2022, then tumbled by 32.11% to $80.3 million in 2023, then decreased by 14.29% to $68.8 million in 2024, then decreased by 16.13% to $57.7 million in 2025.
  • Its Cash & Current Investments stands at $57.7 million for Q3 2025, versus $70.1 million for Q2 2025 and $58.8 million for Q1 2025.